THE EFFICACY OF AGENTS EMPLOYED TO PREVENT ANASTOMOTIC RECURRENCE IN COLORECTAL-CARCINOMA
- 1 January 1984
- journal article
- research article
- Vol. 66 (3) , 192-194
Abstract
Forty-eight of 72 surgeons canvassed in Southwest England [UK] (67%) routinely use an intraluminal cytotoxic agent to prevent suture-line recurrence following partial resection of the large bowel for cancer. The most popular agents are chlorhexidine-cetrimide preparations (n = 14), mercuric perchloride (12), povidone-iodine (7) and water (12); noxythiolin, sodium hypochlorite and silver nitrate are used occasionally. The mean duration of treatment is 2 min. When assayed for cytoxicity against tumor cells freshly prepared from human colorectal carcinomas (n = 10), both chlorhexidine-cetrimide and povidone-iodine were rapidly lethal at a wide range of concentrations (5-100%). Mercuric perchloride (0.2%) was similarly effective, but up to 20% of tumor cells remained viable after exposure to noxythiolin and nearly 30% with water alone. Chlorhexidine-cetrimide and povidone-iodine are the agents of choice to kill malignant cells exfoliated into the colorectal lumen.This publication has 9 references indexed in Scilit:
- ETIOLOGY OF COLONIC SUTURE-LINE RECURRENCE1979
- Cell viability studies on the exfoliated colonic cancer cellBritish Journal of Surgery, 1978
- Intraperitoneal noxytiolin as an experimental chemotherapeutic agentBritish Journal of Surgery, 1973
- Inhibition of the growth of tumour cells in culture by noxytiolinBritish Journal of Surgery, 1972
- Pathogenesis of recurrences on the suture line following surgical resection for carcinoma of the colonCancer, 1967
- EXPERIMENTAL USE OF CETRIMIDE IN THE PREVENTION OF WOUND IMPLANTATION WITH CANCER CELLSThe Lancet, 1966
- ANAL METASTASES FROM CARCINOMA OF THE RECTUM AND COLONAnz Journal of Surgery, 1965
- Implantation from the Bowel Lumen in Cancer of the Large IntestineAnnals of Surgery, 1961
- Trends in the treatment of tumours of the rectum, rectosigmoid and left colon.1955